Details

NameSymbolSector
LYKA LABS LTD.LYKALABSPharmaceuticals
Open
72
High
73.8
Low
69.23
Close
71.82
Volume
32626
Exchange
nse
Time
15-Jun-2026

Outlook

Score:  

2.25

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Lyka Labs is  
High Wave
Estimated Stoploss of Lyka Labs is ₹  
73.8
Lyka Labs has a  
Bearishℹ
 pattern. 
Formation of  
High Wave
 candle pattern indicates the trend direction of Lyka Labs is  
Unpredictableℹ
. 

Trend

Lyka Labs is in  
Uptrendℹ
. 
Price of Lyka Labs is  
Upℹ
 by  

17.97

%. 
Target
Buy @ 

57.16

Sell @ 

77.05

Current @ 

71.82

Volume

The trade volumes of Lyka Labs have become  
Deficientℹ
Though the volume trend for Lyka Labs appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Lyka Labs is  

Down

 by  

55.18

% 

Valuation

The current market price of Lyka Labs is  
Undervaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 176cr and total assets worth ₹ 176cr, the balance sheet of Lyka Labs is:  
Balancedℹ
. 
Cashflow
Lyka Labs has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 4cr

. It is  
Upℹ
 by  

20

%. 

(*Mar 2025)

5.88% i.e. ₹ 1cr earned in operatingℹ
64.71% i.e. ₹ 11cr spent in investingℹ
29.41% i.e. ₹ 5cr earned in financingℹ
0% in otherℹ
Lyka Labs has  
Poorℹ
 cash flow because there is  

Shortage

 of  

₹ 5cr

. It is  
Downℹ
 by  

0

%. 

(*Mar 2024)

9.09% i.e. ₹ 1cr earned in operatingℹ
81.82% i.e. ₹ 9cr spent in investingℹ
9.09% i.e. ₹ 1cr earned in financingℹ
0% in otherℹ
Income
The income of Lyka Labs is  

₹ 37cr

 and  

Loss

 is :  

₹ 3cr

(*Sep 2025)

Lyka Labs Losses increased by:  

400

% and Income is Up by:  

12.12

% 

(*Sep 2025)

The income of Lyka Labs is  

₹ 33cr

 and  

Profit

 is :  

₹ 1cr

(*Jun 2025)

Lyka Labs Profit is down by:  

50

% and Income is Down by:  

2.94

% 

(*Jun 2025)

The income of Lyka Labs is  

₹ 34cr

 and  

Profit

 is :  

₹ 2cr

(*Mar 2025)

Lyka Labs Profit is up by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

By using this site you agree to the use of cookies to deliver a better site experience.